Treating COVID-19: A pharmaceutical executive’s view
McKinsey
MAY 27, 2020
Cedric Francois, the CEO of pharmaceutical company Apellis, discusses possible approaches to treating COVID-19 patients. Insights on Pharmaceuticals & Medical Products
McKinsey
MAY 27, 2020
Cedric Francois, the CEO of pharmaceutical company Apellis, discusses possible approaches to treating COVID-19 patients. Insights on Pharmaceuticals & Medical Products
McKinsey
SEPTEMBER 17, 2020
Our GOLD standard will help transform your pharmaceutical brand and achieve accelerated growth. Asia-Pacific
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
McKinsey
SEPTEMBER 1, 2018
Insights on Pharmaceuticals & Medical ProductsUnderstanding structural shifts in the market can help pharma stakeholders innovate and, ultimately, deliver benefits for patients.
McKinsey
OCTOBER 11, 2018
There are lessons for other industries in the way pharma companies use mergers to innovate, work more efficiently, and bolster product portfolios. Strategy & Corporate Finance Insights
Strategy+Business
FEBRUARY 22, 2018
And although the pharmaceutical and healthcare industries know this is the way forward, they face some significant hurdles Precision medicine combines business opportunities with clinical health benefits.
McKinsey
OCTOBER 27, 2017
The CEO of Eli Lilly offers perspectives on accelerating change in the industry. Our Insights
McKinsey
NOVEMBER 12, 2020
Insights on Pharmaceuticals & Medical ProductsLeaders should consider the lessons and achievements of the COVID-19 crisis in forging new innovation aspirations—and the mechanisms needed to execute them.
McKinsey
OCTOBER 23, 2020
Insights on Pharmaceuticals & Medical ProductsTwo experts discuss how quantum computing can help solve intractable problems in drug discovery and development.
Harvard Business
SEPTEMBER 28, 2020
Sponsor content from Indegene. Innovation Customer service Technology Sponsor Content
McKinsey
DECEMBER 1, 2020
Insights on Pharmaceuticals & Medical ProductsAs adoption of healthcare technology accelerates, it’s a good time for healthcare companies to consider investing in digital among nine potential “value pools.”.
McKinsey & Company
JANUARY 8, 2021
Insights on Pharmaceuticals & Medical ProductsBiopharma in 2020 has shown what it can achieve when it works at its best. How can the industry build on this renewed sense of purpose in the years ahead?
McKinsey
JULY 23, 2019
Pharmaceutical companies are increasingly turning to the concept of agility to help them transform their R&D functions. Insights on Pharmaceuticals & Medical Products
McKinsey
AUGUST 18, 2020
Insights on Pharmaceuticals & Medical ProductsLife-sciences companies have yet to realize the full potential of digital and analytics. Pioneers are finding success by focusing on entire parts of the business system rather than use case projects.
McKinsey
APRIL 25, 2020
Insights on Pharmaceuticals & Medical ProductsBiopharmas should consider five areas as they deal with the crisis.
Harvard Business
MARCH 11, 2018
That rule of life is no secret to pharmaceutical companies across the globe. Japan remains the world’s second-biggest pharmaceuticals market, behind only the United States and China. The biggest change for pharma in Japan was the 2014 revision of the nation’s keystone pharmaceuticals law, renamed the PMD Act—for pharmaceutical and medical devices. Older people need more medicine.
McKinsey
SEPTEMBER 17, 2020
Insights on Pharmaceuticals & Medical ProductsThe “fail fast and break things” approach that tech start-ups favor probably won’t work in healthcare. A slower, more deliberate route to market and reimbursement is required.
McKinsey
JULY 24, 2020
Insights on Pharmaceuticals & Medical ProductsHow quickly COVID-19 vaccine production ramps up will depend on technology transfer—the capabilities and processes that can speed vaccines from development to manufacturing. Are we ready?
McKinsey
MAY 14, 2020
Insights on Pharmaceuticals & Medical ProductsAdvances in biological science could transform economies and societies, helping to tackle global challenges from climate change to pandemics.
McKinsey
NOVEMBER 30, 2020
Insights on Pharmaceuticals & Medical ProductsCommercial leaders share the new skills brand marketers need in the digital era to move from brand building to revenue acceleration.
McKinsey
SEPTEMBER 2, 2020
Insights on Pharmaceuticals & Medical ProductsFive interventions have helped manufacturers ease supply constraints for medtech products during the pandemic. Important lessons have been learned along the way.
McKinsey & Company
DECEMBER 15, 2020
As pharmaceutical companies reshape their commercial models to prepare for the uncertainties ahead, personalization and digital enablement will be crucial to launch success in the new environment. Insights on Pharmaceuticals & Medical Products
McKinsey
AUGUST 27, 2020
Insights on Pharmaceuticals & Medical ProductsThe COVID-19 crisis is exacerbating what is considered a critical vulnerability in the health infrastructure of many developing countries—a severe shortage of medical oxygen.
McKinsey
OCTOBER 4, 2019
Blurring the lines between pharmaceuticals and medical technology, cybermedicine has the potential to become a pillar of medical treatment and play a key role in the future of medtech innovation. Insights on Pharmaceuticals & Medical Products
McKinsey
AUGUST 19, 2020
Insights on Pharmaceuticals & Medical ProductsCell and gene therapies promise life-changing treatments, but the pandemic has hit the sector hard. A survey reveals the extent of the disruption and suggests actions to help companies become more resilient.
McKinsey
JULY 23, 2020
Insights on Pharmaceuticals & Medical ProductsLeading pharma companies are applying advanced analytics to real-world evidence generation to deliver impact at scale. How can leaders keep innovating, and what should others do to catch up?
McKinsey & Company
JANUARY 4, 2021
Insights on Pharmaceuticals & Medical ProductsMedical-device innovators need a better way to understand the unmet needs along a patient’s health journey to ensure better clinical outcomes. Ethnographic research offers a path forward.
McKinsey
JUNE 13, 2019
Insights on Pharmaceuticals & Medical ProductsFour core areas of medical-affairs activity combine to maximize patient experiences and outcomes.
McKinsey
OCTOBER 29, 2020
Insights on Pharmaceuticals & Medical Products“What I love about medical devices is this enormous capability to deliver a better way of healthcare to so many people across the world.”.
McKinsey
JUNE 26, 2020
Insights on Pharmaceuticals & Medical ProductsIn a new survey of 100 executives, respondents expect most employees to be working on-site by December. To do so, they are implementing a range of interventions that could transform how people work.
McKinsey & Company
JANUARY 19, 2021
Insights on Pharmaceuticals & Medical ProductsThe speed at which scientific breakthroughs in cell and gene therapy translate into advances in European healthcare could depend on how quickly stakeholders address some uniquely European challenges.
McKinsey
JULY 30, 2020
Insights on Pharmaceuticals & Medical ProductsInnovators are sprinting to develop inoculations against the novel coronavirus. Here, we summarize the latest information on research timelines and the potential impact of a vaccine on the pandemic—and society.
McKinsey
DECEMBER 15, 2018
A McKinsey study points to areas pharmaceutical companies can address to combat this long-standing industry issue. Insights on Pharmaceuticals & Medical ProductsWhen patients fail to follow prescribed medical regimens, outcomes suffer.
McKinsey
DECEMBER 18, 2018
Insights on Pharmaceuticals & Medical ProductsSix levers can help healthcare and pharma players achieve better outcomes when using machine learning.
McKinsey
MAY 20, 2020
Governments, healthcare providers, and pharmaceutical companies are battling COVID-19 on different fronts. Insights on Pharmaceuticals & Medical ProductsThermo Fisher Scientific is at the nexus of all of these endeavors.
McKinsey
OCTOBER 28, 2020
Insights on Pharmaceuticals & Medical ProductsThe coronavirus pandemic has forced many changes in how life sciences work is done. It may be a misconception that this is the next normal.
Harvard Business
SEPTEMBER 23, 2020
Race Pharmaceuticals Digital ArticleHow scientific institutions can address systemic racism.
McKinsey
NOVEMBER 9, 2018
Insights on Pharmaceuticals & Medical ProductsHow can medtech companies thrive in the world’s fastest-growing market?
McKinsey
AUGUST 27, 2020
Insights on Pharmaceuticals & Medical ProductsSignificant increases in incidence rates have made cancer a high priority in China. Progress has resulted from innovative treatments and greater access to care, yet much more needs to be done.
McKinsey
DECEMBER 14, 2019
Insights on Pharmaceuticals & Medical ProductsUnlocking the full potential of CAR T-cell therapies requires investment in four areas.
McKinsey
JULY 15, 2020
Insights on Pharmaceuticals & Medical ProductsTesting is considered critical to containing COVID-19, yet many countries have encountered diagnostic-supply shortages. Understanding where constraints lie could help efforts to scale testing.
Let's personalize your content